Jerold Martin

Jerold Martin is Senior Vice President, Scientific Affairs, at Pall Life Sciences, Biopharmaceuticals Group, and Chairman of the Board and Technology Committee of the Bio-Process Systems Alliance (BPSA). jerold_martin@pall.com

There is no harmonized guidance on pre-use integrity testing of sterilizing filters, prompting discussion among users as to whether such testing is necessary.

This column will address some of the questions on how single use systems are sterilized by gamma irradiation and what documentation may be requested by regulators.

Jerold Martin, senior vice president global technical affairs, at Pall Life Sciences, explains the importance and impact of single-use systems in sterile environments.

June and July saw three major US conferences on implementing single-use technologies: the IBC Single-use Applications meeting, the PDA Single-use Workshop and the Bio-Process Systems Alliance (BPSA) International Single-use Summit (ISUS). Jerold Martin highlights some of the key topics discussed at these meetings.

Strategies to minimise particle levels in the finished product when using single-use technologies downstream of final filters.

Regions around the world are starting to follow the US trend in disposables and are working to solve common challenges.

Over the past 10 years or so, we've seen single-use technologies explode from production-scale filter capsules, tubing and simple biocontainers to encompass sterile connectors, membrane chromatography adsorbers, bioreactors, mixers, and integrated platform systems with increasing levels of sensors and automated controls.

The development of quality agreements has long been recognised as a critical activity to ensure a product's quality meets regulatory requirements.

What have been the key innovations that have shaped current aseptic practices and techniques?